CG
HALO icon

Cutler Group’s Halozyme HALO Stock Holding History

Cutler Group’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4,700
Closed -$3K – 4450
2018
Q1 		$3K Sell
4,700
-1,900
-29% -$36.8K ﹤0.01% 3562
2017
Q4 		$4K Buy
6,600
+4,200
+175% +$77.2K ﹤0.01% 3778
2017
Q3 		$8K Sell
2,400
-9,400
-80% -$127K ﹤0.01% 3982
2017
Q2 		$8K Sell
11,800
-13,600
-54% -$182K ﹤0.01% 4364
2017
Q1 		$12K Buy
+25,400
New +$321K ﹤0.01% 3858
2016
Q1 		– Sell
-4,000
Closed -$5K – 6747
2015
Q4 		$5K Buy
+4,000
New +$63.8K ﹤0.01% 4885

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cutler Group's HALO Position: Q1 2021 in Review

Cutler Group sold out of Halozyme (HALO) in Q1 2021, closing a stake of 5,500 shares — an estimated $234K sold.

Cutler Group first reported a position in HALO in Q4 2015 and held it in 18 quarters. The position peaked at $423K in Q4 2015. 336 funds tracked by Wall St. Rank hold HALO as of Q1 2021.

  • Cutler Group reported no remaining Halozyme position as of Q1 2021 after selling out during the quarter.
  • Cutler Group sold 5,500 Halozyme shares in Q1 2021, an estimated $234K.
  • Cutler Group first reported a position in Halozyme in Q4 2015 and held it in 18 quarters.
  • Cutler Group's Halozyme position peaked at $423K in Q4 2015.
  • 336 funds tracked by Wall St. Rank held Halozyme as of Q1 2021.

Based on Cutler Group's 13F filing for Q1 2021, filed 26 Apr 2021.